I. Mazurier

548 total citations
11 papers, 348 citations indexed

About

I. Mazurier is a scholar working on Infectious Diseases, Neurology and Genetics. According to data from OpenAlex, I. Mazurier has authored 11 papers receiving a total of 348 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Infectious Diseases, 4 papers in Neurology and 3 papers in Genetics. Recurrent topics in I. Mazurier's work include Chronic Lymphocytic Leukemia Research (3 papers), COVID-19 Clinical Research Studies (3 papers) and Lymphoma Diagnosis and Treatment (3 papers). I. Mazurier is often cited by papers focused on Chronic Lymphocytic Leukemia Research (3 papers), COVID-19 Clinical Research Studies (3 papers) and Lymphoma Diagnosis and Treatment (3 papers). I. Mazurier collaborates with scholars based in France. I. Mazurier's co-authors include Didier A. Colin, Viviane Finck‐Barbançon, Marie Bossert, Vincent Gendrin, Souheil Zayet, Timothée Klopfenstein, Thierry Conrozier, Anne Lohse, Julio Badié and Chaouki Mezher and has published in prestigious journals such as Infection and Immunity, Microbes and Infection and FEMS Microbiology Letters.

In The Last Decade

I. Mazurier

11 papers receiving 340 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
I. Mazurier France	5	291	173	73	47	23	11	348
Polina Sonis Israel	8	320 1.1×	162 0.9×	54 0.7×	104 2.2×	61 2.7×	14	443
Veronika Zsikla Switzerland	6	147 0.5×	73 0.4×	73 1.0×	41 0.9×	31 1.3×	7	290
Rina Falb Israel	6	394 1.4×	218 1.3×	48 0.7×	94 2.0×	60 2.6×	11	494
Simon Eschweiler United Kingdom	4	257 0.9×	113 0.7×	65 0.9×	192 4.1×	85 3.7×	5	449
Giulia Baresi Italy	4	207 0.7×	60 0.3×	40 0.5×	91 1.9×	19 0.8×	4	269
Blanka Kaplan United States	7	114 0.4×	58 0.3×	26 0.4×	106 2.3×	24 1.0×	22	278
Sreya Ghosh United States	6	216 0.7×	57 0.3×	137 1.9×	184 3.9×	40 1.7×	10	494
Barbara Baronio Italy	3	187 0.6×	61 0.4×	31 0.4×	81 1.7×	20 0.9×	4	258
Mélia Magnen United States	8	111 0.4×	30 0.2×	61 0.8×	61 1.3×	32 1.4×	12	292
Eric Y. T. Chan China	6	179 0.6×	43 0.2×	48 0.7×	146 3.1×	15 0.7×	6	302

Countries citing papers authored by I. Mazurier

Since Specialization

Citations

This map shows the geographic impact of I. Mazurier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. Mazurier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. Mazurier more than expected).

Fields of papers citing papers by I. Mazurier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I. Mazurier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. Mazurier. The network helps show where I. Mazurier may publish in the future.

Co-authorship network of co-authors of I. Mazurier

This figure shows the co-authorship network connecting the top 25 collaborators of I. Mazurier. A scholar is included among the top collaborators of I. Mazurier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I. Mazurier. I. Mazurier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Lohse, Anne, Timothée Klopfenstein, Pierre‐Yves Royer, et al.. (2020). Predictive factors of mortality in patients treated with tocilizumab for acute respiratory distress syndrome related to coronavirus disease 2019 (COVID-19). Microbes and Infection. 22(9). 500–503. 14 indexed citations

Klopfenstein, Timothée, Souheil Zayet, Anne Lohse, et al.. (2020). Tocilizumab therapy reduced intensive care unit admissions and/or mortality in COVID-19 patients. Médecine et Maladies Infectieuses. 50(5). 397–400. 178 indexed citations

Conrozier, Thierry, Anne Lohse, Jean‐Charles Balblanc, et al.. (2020). Biomarker variation in patients successfully treated with tocilizumab for severe coronavirus disease 2019 (COVID-19): results of a multidisciplinary collaboration.. PubMed. 38(4). 742–747. 32 indexed citations

Mazurier, I., Meyer‐Michel Samama, Martine Alhenc‐Gelas, et al.. (2012). Nécroses cutanées tardives sous fluindione révélant un déficit en protéine C. Annales de Dermatologie et de Vénéréologie. 139(3). 199–203. 4 indexed citations

Struski, Stéphanie, Vincent Leymarie, Catherine Hélias, et al.. (2006). Étude cytologique, immunophénotypique et cytogénétique d'une série de 136 cas consécutifs d'hémopathies lymphoïdes chroniques à cellules B matures. Pathologie Biologie. 55(1). 59–72. 2 indexed citations

Mazurier, I., et al.. (2006). Aberrant CD8 Expression in B-Chronic Lymphocytic Leukemia: Report of Five Cases. Acta Haematologica. 115(1-2). 74–77. 11 indexed citations

Chenard, Marie‐Pierre, et al.. (2003). [An unusual cause of pancytopenia: intravascular lymphoma].. PubMed. 154(4). 252–4. 3 indexed citations

Mazurier, I., et al.. (2003). [Simultaneous occurrence of Sézary syndrome and B-cell chronic lymphocytic leukaemia].. PubMed. 61(1). 94–8. 1 indexed citations

Audemar, Franck, et al.. (1999). [Left branch portal vein thrombosis associated with hyperhomocysteinemia].. PubMed. 23(12). 1388–91. 4 indexed citations

10.

Colin, Didier A., et al.. (1994). Interaction of the two components of leukocidin from Staphylococcus aureus with human polymorphonuclear leukocyte membranes: sequential binding and subsequent activation. Infection and Immunity. 62(8). 3184–3188. 98 indexed citations

11.

Prévost, Gilles, et al.. (1992). A structurally novel staphylococcal protein A from the V8 strain. FEMS Microbiology Letters. 91(1). 1–8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact